Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2003

View Archived Issues

Preclinical and clinical data on natalizumab presented at DDW 2003

Fondaparinux better than enoxaparin in preventing postsurgical venous thromboembolism

Thalidomide delays sepsis in an experimental model

Antifungal effects of N-chlorotaurine described in Glasgow

Effects of gamma-linolenic acid and arachidonic acid on the efficacy of antimicrobials

Pleconaril is well tolerated and reduces morbidity associated with picornavirus infection

CDP-571 safe, effective in patients with Crohn's disease

Mutational studies and postantibiotic effect of DK-507k and other fluoroquinolones

Enanta reports new aspartyl protease inhibitors with utility in HIV infection

ExonHit Therapeutics claims novel antitumor compounds in recent patent

Immune-selective proteasome inhibitors under study at Kyorin and Nisshin Pharma

Water-soluble etoposide prodrugs prepared and tested by French research team

CNRS researchers design novel antimalarial artemisinin derivatives

Sankyo describes new compounds with PPARgamma-agonist and antitumor activity

New 5-HT2B receptor antagonists for pain and other uses described in Biofrontera patent

Novel modulators of cellular calcium influx and their use reported by Ono

Kirin identifies new antitumor FGFR inhibitors

Chiron makes offer for PowderJect

Bextra approved in Europe

FDA review date set for Crestor

King and Elan restructure primary care acquisition agreement

TroVax trial in renal cancer cleared to begin

Remicade approved in E.U. for maintenance therapy in Crohn's disease

First anti-TNF agent approved for ankylosing spondylitis in E.U.

Millennium ships Velcade within a week of FDA approval

Intravitreal Posurdex safe and effective in persistent macular edema

New data on gabapentin combined with valaciclovir in postherpetic neuralgia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....